Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C.

Antimicrobial agents and chemotherapy - 1 Feb 2009

Yee Leland J, Im KyungAh, Wahed Abdus S, Bugawan Teodorica, Li Jia, Rhodes Shannon L, Erlich Henry, Rosen Hugo R, Liang T Jake, Yang Huiying

Abstract excerpt

The dynamics of the viral decline immediately after the start of therapy for chronic hepatitis C virus (HCV) infection may have prognostic potential for ultimate sustained virologic response. Considerable interindividual variability in the decline has been reported, including differences by race....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, MHC Class I
Share to Genes, MHC Class II
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Major Histocompatibility Complex

Share to Models, Statistical

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 18852273
DOI: 10.1128/AAC.00947-08
PMCID: PMC2630649

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18852273-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C.PMID 18852273Read ↗

Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection.Semantic proximity Read ↗

Human leukocyte antigen–associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution†Semantic proximity Read ↗

Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy.Semantic proximity Read ↗

HLA-Associated Clinical Progression Correlates with Epitope Reversion Rates in Early Human Immunodeficiency Virus InfectionSemantic proximity Read ↗

The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C.Semantic proximity Read ↗

Racial differences in HLA class II associations with hepatitis C virus outcomes.Semantic proximity Read ↗

Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.Semantic proximity Read ↗

Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1.Semantic proximity Read ↗

HLA class II genes determine the natural variance of hepatitis C viral load.Semantic proximity Read ↗

CD8 epitope escape and reversion in acute HCV infection.Semantic proximity Read ↗

Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy.Semantic proximity Read ↗

Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.